Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-20-008429

Options or other derivatives

  • SVP and CFO acquired 1,052,631 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Konidaris Tasos SVP and CFO 2020-03-12 Grant or award · Restricted Stock Units +350,877 350,877 D
Konidaris Tasos SVP and CFO 2020-03-12 Grant or award · Performance-Based Restricted Stock Units +701,754 701,754 D
Loading xslF345X03/doc4.xml…